Autosomal Dominant Hypocalcemia clinical trials at UCSF
2 in progress, 0 open to eligible people
Encaleret Compared to Standard of Care in Participants with ADH1
Sorry, in progress, not accepting new patients
The primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1).
Oakland, California and other locations
ADH1 and ADH2 Disease Monitoring Study (DMS)
Sorry, in progress, not accepting new patients
A global, multi-center, Disease Monitoring Study (DMS) in participants with Autosomal Dominant Hypocalcemia Type 1 (ADH1) or Autosomal Dominant Hypocalcemia Type 2 (ADH2) designed to characterize ADH1 and ADH2 disease presentation and progression through retrospective (past) and longitudinal prospective (over time into the future) data collection.
Oakland, California and other locations
Last updated: